Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1900441

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1900441

Drug of Abuse Testing Market Size, Share, and Growth Analysis, By Product Type (Analyzers, Rapid Testing Devices), By Sample Type (Saliva, Breath), By Application, By End-user, By Region - Industry Forecast 2026-2033

PUBLISHED:
PAGES: 198 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global Drug of Abuse Testing Market size was valued at USD 4.02 Billion in 2024 and is poised to grow from USD 4.25 Billion in 2025 to USD 6.68 Billion by 2033, growing at a CAGR of 5.8% during the forecast period (2026-2033).

The global drug of abuse testing market is witnessing robust growth driven by the rising incidence of substance abuse, strict industry regulations, and heightened awareness of the significance of drug testing in healthcare and workplace environments. A substantial demand for drug testing services is emerging to combat substance abuse, alongside government initiatives promoting compliance and awareness. Increased production and trade of illicit drugs further underscore the necessity for testing services. However, challenges such as limitations in detecting trace amounts of certain substances and the potential impact of evolving drug legalization laws pose risks to market dynamics. Despite these obstacles, innovations in testing technologies and the integration of drug screening with healthcare services present significant opportunities for market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Drug of Abuse Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Drug of Abuse Testing Market Segments Analysis

Global Drug of Abuse Testing Market is segmented by Product Type, Sample Type, Testing Type, End-user and region. Based on Product Type, the market is segmented into Analyzers, Rapid Testing Devices and Consumables. Based on Sample Type, the market is segmented into Saliva, Breath, Urine, Blood and Hair & Sweat. Based on Application, the market is segmented into Medical Screening, Monitoring Pain Management, Forensic & Legal Information, Employment Drug Testing, Sports & Athletics Testing. Based on End-user, the market is segmented into Hospitals, Diagnostics Laboratories, On-the-spot Testing and Forensic Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Drug of Abuse Testing Market

The increasing production, consumption, and distribution of both new and illicit drugs are significant factors driving the demand for Drug of Abuse (DoA) testing, consequently stimulating market growth. The high prevalence of drug users highlights the urgent need for effective DoA testing solutions, propelling the industry forward. Furthermore, government initiatives designed to raise awareness about drug abuse and promote compliance within organizations are expected to support market expansion. Additionally, there is a rising demand for testing products that provide enhanced specificity and sensitivity in detecting designer drugs, which further strengthens the growth of the Drug of Abuse testing market.

Restraints in the Global Drug of Abuse Testing Market

The Global Drug of Abuse Testing market is encountering significant obstacles that may hinder its growth potential. One primary concern is the inadequacy of existing testing products, which struggle to effectively detect minute quantities of certain drugs. Furthermore, the ongoing shifts in legislation aimed at legalizing recreational and illicit substances present additional challenges for market expansion. Comprehensive assessments of the market reveal crucial insights into recent advancements, regulatory frameworks, trade dynamics, value chain efficiency, competitive landscape, emerging opportunities, and technological progressions. Addressing these factors is essential for stakeholders looking to navigate the evolving environment of drug testing and capitalize on future growth prospects.

Market Trends of the Global Drug of Abuse Testing Market

The Global Drug of Abuse Testing market is witnessing a pronounced shift towards the increasing adoption of point-of-care testing solutions. This trend highlights a growing demand for rapid and accessible drug testing methods that can be conducted in various non-laboratory environments, including clinics, workplaces, and remote locations. The convenience and immediacy of obtaining test results at the point of care cater to the rising need for timely interventions, particularly in emergency and occupational health contexts. As stakeholders prioritize efficiency and flexibility, innovations in testing technology are further propelling this movement, shaping the future landscape of drug abuse testing solutions.

Product Code: SQMIG35H2250

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies

Global Drug of Abuse Testing Market Size by Product Type & CAGR (2026-2033)

  • Market Overview
  • Analyzers
    • Immunoassays Analyzers
    • Chromatographic Devices
    • Breath Analyzers
  • Rapid Testing Devices
    • Urine Testing Devices
    • Oral Fluid Testing Devices
  • Consumables
    • Fluid Collection Devices
    • Others

Global Drug of Abuse Testing Market Size by Sample Type & CAGR (2026-2033)

  • Market Overview
  • Saliva
  • Breath
  • Urine
  • Blood
  • Hair & Sweat

Global Drug of Abuse Testing Market Size by Application & CAGR (2026-2033)

  • Market Overview
  • Medical Screening
  • Monitoring Pain Management
  • Forensic & Legal Information
  • Employment Drug Testing
  • Sports & Athletics Testing

Global Drug of Abuse Testing Market Size by End-user & CAGR (2026-2033)

  • Market Overview
  • Hospitals
  • Diagnostics Laboratories
  • On-the-spot Testing
  • Forensic Laboratories

Global Drug of Abuse Testing Market Size & CAGR (2026-2033)

  • North America (Product Type, Sample Type, Application, End-user)
    • US
    • Canada
  • Europe (Product Type, Sample Type, Application, End-user)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product Type, Sample Type, Application, End-user)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product Type, Sample Type, Application, End-user)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product Type, Sample Type, Application, End-user)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Abbott Laboratories (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens Healthineers AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • F. Hoffmann-La Roche Ltd (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Quest Diagnostics Incorporated (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Dragerwerk AG & Co. KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biomerieux SA (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shimadzu Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Randox Laboratories Ltd. (United Kingdom)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Psychemedics Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sonic Healthcare (Australia)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LabCorp (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MP Biomedicals LLC (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Omega Laboratories, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Express Diagnostics International Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sciteck, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!